HistoGeneTM LCM Immunofluorescence Kit Preserve RNA Integrity during Immunofluorescence Processing Simplify Fluorescent Target Cell Labeling
Identify target cells for Laser CaptureMicrodissection (LCM) and gene expressionanalysis using antigen markers to highlightspecific surface or intracellular proteins. TheHistoGene LCM ImmunofluorescenceStaining Kit is the only Kit specifically designedfor retrieval of high-quality RNA fromimmunofluorescently stained frozen tissuesections. The Staining Kit provides reagents andslides for convenient and reliable immuno-fluorescent staining. The Kit provides aprotocol streamlined and optimized to maintainRNA quality and materials sufficient forprocessing 32 slides. Chill Samples Get Brilliant High-contrast for Intact RNA Label Intensity
The HistoGene LCM Immunofluorescence Kitemploys a biotin-avidin system with Cy3 whichleads to exceptionally good staining intensity andspecificity. The Kit is used with a primarybiotinylated monoclonal antibody to an antigen ofchoice provided by the user and Cy3-conjugated
Laser Capture Microdissection (LCM) of human prostate ductal epithelium prepared with the HistoGene LCM Immuno-
streptavidin is included in the Kit. fluorescence Kits.Panel A. Human prostate stained with an anti-
cytokeratin antibody, before LCM. Panel B. Image of the captured
cytokeratin positive cells on the cap after LCM. Use A Quick 15-minute Process to Preserve RNA
To increase RNA yield and ensure its quality,
the HistoGene Cold Block keeps up to four
generally take over 90 minutes to process
tissue section slides and several tubes containing
samples, compromising the RNA integrity with
buffer and antibody solutions chilled during
conditions sub-optimal for single-stranded
processing. The block is designed for use with
Identify target cells using the HistoGene LCM Immuno-
the CoolSafe triple density polysterene cooler
protocol takes less than 15 minutes (only 5
fluorescence Staining Kit. Panel A. Human foreskin stained with
(Cat. # CSF-Box) and –10ºC CoolBrick (Cat. #
anti-CD1a antibody. Panel B. Human jejunum stained with anti-Pan-
cytokeratin antibody. Panel C. Mouse lacrimal gland inflammatory
performed using Arcturus’ proprietary staining
infiltrate stained with anti-CD4 antibody. Panel D. Mouse small
buffer, which minimizes RNA degradation.
intestine stained with anti- MAdCAM-1 antibody.
Electrophoresis and RT-PCR of RNA isolatedafter using the HistoGene Immuno-fluorescence Kit confirm that high-qualityRNA is retrieved from microdissected samples. (Data on back page.)
Comparison of RNA quality before and Obtain Intact RNA from after processing using the HistoGene LCM Immunofluorescence Kit. RNA was Many Tissue Types
Arcturus scientists have examined RNA integrity
(Lane 1), and from frozen section of small
intestine stained using the HistoGene LCM
after using the HistoGene Immunofluorescence
Kit on many tissue types with several antibodies.
vascular expression of MAdCAM-1 (Lane 2).
All tissue tested using the HistoGene Immuno-
Electrophoretic analysis of total cellular
fluorescence Kits have yielded high-quality RNA. Detection of low- and high-abundance, full-length RNA in HistoGene LCM immunofluorescent stained samples. RT-PCR was
performed on RNA from 500–1000 cells captured from different
Validated Tissue-Antibody Sets
tissues. Equal quantities of cDNA were analyzed with primers
detecting 3’ and 5 ‘ ends of low-abundance ADP ribosylation factor
Antibody
1 ( ARF-F1), (3’; 239 bp, 5’; 336 bp) and 5’ end clathrin gene which
Use Microgenomics Products
has a transcript length over 6 kb (570 bp) (primer sets from KPL,
Inc.). M: molecular-weight markers. Lane 1: human breast tissue, ARF-
for Microarray Analysis
F1, 5’. Lane 2: mouse brain, ARF-F1, 5’. Lane 3: mouse spleen, ARF-F1,
3’. Lane 4: mouse lacrimal gland, ARF-F1 3’. Lane 5: mouse lacrimal
gland, clathrin. Lane 6: human prostate, clathrin. Lane 7: negative
The HistoGene LCM Immunofluorescence Kit is
RT control, human prostate, clathrin.
Microgenomics–products designed to seamlessly
work together to produce high-quality expression
microarray data from pure cell populations.
Use HistoGene-stained samples with thePixCell® IIe LCM System or the AutoPix®Automated LCM System to capture pure cellpopulations of fluorescently labeled target cells. Ordering Information Expression microarray of LCM samples prepared using Arcturus’ Catalog # Description
numbers of cells with the PicoPure RNA
HistoGene LCM Immunofluorescence, PicoPure RNA Isolation,
Isolation Kit. Next, amplify nanogram quantities
and RiboAmp® RNA Amplification Kits. Human breast tumor
Staining Kit, reagents for staining 32 slides
of RNA to micrograms using the RiboAmp® RNA tissue sections were stained for cytokeratin using the HistoGeneAmplification Kit, which provides amplified
LCM Immunofluorescence Kit and 1000- positively stained cells
were microdissected. RNA was isolated using the PicoPure RNA
Isolation Kit and amplified with the RiboAmp RNA Amplification Kit.
Amplified RNA was converted to Cy5 labeled cDNA and hybridized
Related Products
to a 24,000 element human cDNA array and scanned. Catalog # Description HistoGene LCM Immunofluorescence Kit Components
· HistoGene Buffer A (4 ml)· HistoGene Buffer B (60 ml)
· HistoGene LCM Immunofluorescence Staining
RiboAmp® HS RNA Amplification Kit,enough for 5 two-round amplifications
PicoPure RNA Isolation Kit, enough for40 isolations
RiboAmp, PicoPure, HistoGene, PixCell and CapSure are
trademarks owned by Arcturus. All other trademarks shown are
the property of their respective owners. Polymerase Chain
Reaction (PCR) is a patented process owned by Hoffman-La
Arcturus Bioscience, Inc. 400 Logue Avenue
Drug Therapy European Parkinson’s Disease Association PARKINSON’S DISEASE AND MOVEMENT DISORDER SOCIETY. This guide has been produced to provide general information about medications for people with Parkinson’s disease (PD), and to detail information about each drug. It is important to bear in mind when referring to the guide that no two people with Parkinson’s are exactly the sa
Sustainable Forests (Timber) Act 2004 APPROVAL OF VICFORESTS TIMBER RELEASE PLAN Timber Release Plan - Background VicForests has prepared a Timber Release Plan as contemplated in Part 5 of the Sustainable Forests (Timber) Act 2004 ( the Act ). Part 5 requires VicForests to prepare a plan in respect of an area to which an Allocation Order applies for the purposes of: (a) harvest